Ken Kelley – PaxVax

Ken Kelley is Chairman/CEO of PaxVax, a social biotech venture developing pill forms of vaccines. PaxVax business model is to run a for-profit in the First World supporting a non-profit in the Third World. Investors to date support this double bottom line model. PaxVax is currently raising a second round of capital to support clinical trials of its Swine Flu Pill vaccine. PaxVax is targeting influenza (Swine Flu H1N1, Bird Flu H5N1) as well as the world